Antitrust Cases filed in the US District Court for the Northern District of Illinois
Locals 302 & 612 of the International Union of Operating Engineers-Employers Construction Industry Health and Security Trust Fund v. AbbVie Inc. et al
as 1:2019cv02799
Defendant: Mylan Pharmaceuticals, Inc., Sandoz, Inc., Momenta Pharmaceuticals, Inc. and others
Plaintiff: Locals 302 & 612 of the International Union of Operating Engineers-Employers Construction Industry Health and Security Trust Fund
Cause Of Action: 15 U.S.C. § 1
Welfare Plan of the International Union of Operating Engineers Locals 137, 137A, 137B, 137C, 137R v. AbbVie, Inc. et al
as 1:2019cv02226
Defendant: Amgen, Inc., AbbVie, Inc. and AbbVie Biotechnology, Ltd.
Plaintiff: Welfare Plan of the International Union of Operating Engineers Locals 137, 137A, 137B, 137C, and 137R and Welfare Plan of the International Union of Operating Engineers Locals 137, 137A, 137B, 137C, 137R
Cause Of Action: 28 U.S.C. § 1331
In Re: Humira (Adalimumab) Antitrust Litigation We have downloadable decisions or orders for this case
as 1:2019cv01873
Defendant: MYLAN PHARMACEUTICALS, INC., SANDOZ, INC., MOMENTA PHARMACEUTICALS, INC. and others
Plaintiff: UFCW LOCAL 1500 WELFARE FUND, Plaintiffs, Locals 302 & 612 of the International Union of Operating Engineers-Employers Construction Industry Health and Security Trust Fund and others
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
International Union of Operating Engineers et al v. Endo Health Solutions, Inc. et al
as 1:2014cv07742
Plaintiff: International Union of Operating Engineers and Local 138 Welfare Fund
Defendant: Endo Health Solutions, Inc. , Endo Pharmaceuticals, Inc. , Penwest Pharmaceuticals Co. and others
Cause Of Action: 15 U.S.C. § 1

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?